{"transactions":[{"id":1530959,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-05-02T22:05:06.000Z","date":"2024-05-02","kind":"exercise","planned":true,"acquired":false,"shares":29350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":29350},"source":{"system":"sec-edgar","filing":"0001225208-24-005500","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005500/doc4.xml","form_type":"4"}},{"id":1530958,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-02T22:05:06.000Z","date":"2024-05-02","kind":"sale","planned":true,"acquired":false,"shares":17143,"price":84.59,"value":1450126.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $83.860 to $84.860. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4485.82,"source":{"system":"sec-edgar","filing":"0001225208-24-005500","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005500/doc4.xml","form_type":"4"}},{"id":1530957,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-02T22:05:06.000Z","date":"2024-05-02","kind":"sale","planned":true,"acquired":false,"shares":12207,"price":85.02,"value":1037839.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $84.865 to $85.420. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21628.82,"source":{"system":"sec-edgar","filing":"0001225208-24-005500","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005500/doc4.xml","form_type":"4"}},{"id":1530956,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-02T22:05:06.000Z","date":"2024-05-02","kind":"exercise","planned":true,"acquired":true,"shares":29350,"price":36.75,"value":1078612.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."}],"balance_after":33835.82,"source":{"system":"sec-edgar","filing":"0001225208-24-005500","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005500/doc4.xml","form_type":"4"}},{"id":1548095,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-04-04T22:26:16.000Z","date":"2024-04-04","kind":"exercise","planned":true,"acquired":false,"shares":29350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":29350,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":29350},"source":{"system":"sec-edgar","filing":"0001225208-24-004959","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004959/doc4.xml","form_type":"4"}},{"id":1548094,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-04T22:26:16.000Z","date":"2024-04-04","kind":"sale","planned":true,"acquired":false,"shares":16618,"price":92.7,"value":1540488.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $92.125 to $93.120. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4485.82,"source":{"system":"sec-edgar","filing":"0001225208-24-004959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004959/doc4.xml","form_type":"4"}},{"id":1548093,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-04T22:26:16.000Z","date":"2024-04-04","kind":"sale","planned":true,"acquired":false,"shares":9820,"price":91.54,"value":898922.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $91.120 to $92.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21103.82,"source":{"system":"sec-edgar","filing":"0001225208-24-004959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004959/doc4.xml","form_type":"4"}},{"id":1548092,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-04T22:26:16.000Z","date":"2024-04-04","kind":"sale","planned":true,"acquired":false,"shares":2712,"price":93.72,"value":254168.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $93.130 to $94.130. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30923.82,"source":{"system":"sec-edgar","filing":"0001225208-24-004959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004959/doc4.xml","form_type":"4"}},{"id":1548091,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-04T22:26:16.000Z","date":"2024-04-04","kind":"sale","planned":true,"acquired":false,"shares":200,"price":94.19,"value":18838.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $94.185 to $94.200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":33635.82,"source":{"system":"sec-edgar","filing":"0001225208-24-004959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004959/doc4.xml","form_type":"4"}},{"id":1548090,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-04T22:26:16.000Z","date":"2024-04-04","kind":"exercise","planned":true,"acquired":true,"shares":29350,"price":36.75,"value":1078612.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."}],"balance_after":33835.82,"source":{"system":"sec-edgar","filing":"0001225208-24-004959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004959/doc4.xml","form_type":"4"}},{"id":1604344,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-03-05T00:16:27.000Z","date":"2024-03-04","kind":"exercise","planned":true,"acquired":false,"shares":29350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":58700,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":29350},"source":{"system":"sec-edgar","filing":"0001225208-24-003505","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824003505/doc4.xml","form_type":"4"}},{"id":1604343,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-05T00:16:27.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":16040,"price":87.05,"value":1396282.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $86.63 to $87.56. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4485.82,"source":{"system":"sec-edgar","filing":"0001225208-24-003505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824003505/doc4.xml","form_type":"4"}},{"id":1604342,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-05T00:16:27.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":13310,"price":86.21,"value":1147455.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $85.62 to $86.60. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20525.82,"source":{"system":"sec-edgar","filing":"0001225208-24-003505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824003505/doc4.xml","form_type":"4"}},{"id":1604341,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-05T00:16:27.000Z","date":"2024-03-04","kind":"exercise","planned":true,"acquired":true,"shares":29350,"price":36.75,"value":1078612.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."}],"balance_after":33835.82,"source":{"system":"sec-edgar","filing":"0001225208-24-003505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824003505/doc4.xml","form_type":"4"}},{"id":1659676,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-02-05T23:37:44.000Z","date":"2024-02-05","kind":"exercise","planned":true,"acquired":false,"shares":29350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":88050,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":29350},"source":{"system":"sec-edgar","filing":"0001225208-24-001597","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001597/doc4.xml","form_type":"4"}},{"id":1659675,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-05T23:37:44.000Z","date":"2024-02-05","kind":"sale","planned":true,"acquired":false,"shares":12167,"price":87.55,"value":1065220.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $87.110 to $88.105. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4485.82,"source":{"system":"sec-edgar","filing":"0001225208-24-001597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001597/doc4.xml","form_type":"4"}},{"id":1659674,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-05T23:37:44.000Z","date":"2024-02-05","kind":"sale","planned":true,"acquired":false,"shares":9761,"price":86.44,"value":843740.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $86.100 to $87.070. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":16652.82,"source":{"system":"sec-edgar","filing":"0001225208-24-001597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001597/doc4.xml","form_type":"4"}},{"id":1659673,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-05T23:37:44.000Z","date":"2024-02-05","kind":"sale","planned":true,"acquired":false,"shares":6422,"price":88.63,"value":569181.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $88.210 to $89.200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26413.82,"source":{"system":"sec-edgar","filing":"0001225208-24-001597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001597/doc4.xml","form_type":"4"}},{"id":1659672,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-05T23:37:44.000Z","date":"2024-02-05","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":89.61,"value":89610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $89.390 to $90.080. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":32835.82,"source":{"system":"sec-edgar","filing":"0001225208-24-001597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001597/doc4.xml","form_type":"4"}},{"id":1659671,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-05T23:37:44.000Z","date":"2024-02-05","kind":"exercise","planned":true,"acquired":true,"shares":29350,"price":36.75,"value":1078612.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."}],"balance_after":33835.82,"source":{"system":"sec-edgar","filing":"0001225208-24-001597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001597/doc4.xml","form_type":"4"}},{"id":1686183,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-01-06T00:19:49.000Z","date":"2024-01-05","kind":"exercise","planned":true,"acquired":false,"shares":29350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":117400,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":29350},"source":{"system":"sec-edgar","filing":"0001225208-24-000480","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824000480/doc4.xml","form_type":"4"}},{"id":1686182,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-06T00:19:49.000Z","date":"2024-01-05","kind":"sale","planned":true,"acquired":false,"shares":26850,"price":72.94,"value":1958439.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $72.41 to $73.41. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4485.82,"source":{"system":"sec-edgar","filing":"0001225208-24-000480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824000480/doc4.xml","form_type":"4"}},{"id":1686181,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-06T00:19:49.000Z","date":"2024-01-05","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":73.46,"value":183650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $73.42 to $73.59. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":31335.82,"source":{"system":"sec-edgar","filing":"0001225208-24-000480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824000480/doc4.xml","form_type":"4"}},{"id":1686180,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-06T00:19:49.000Z","date":"2024-01-05","kind":"exercise","planned":true,"acquired":true,"shares":29350,"price":36.75,"value":1078612.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."}],"balance_after":33835.82,"source":{"system":"sec-edgar","filing":"0001225208-24-000480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824000480/doc4.xml","form_type":"4"}},{"id":1713020,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-12-14T00:04:46.000Z","date":"2023-12-13","kind":"exercise","planned":true,"acquired":false,"shares":29350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":146750,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":29350},"source":{"system":"sec-edgar","filing":"0001225208-23-011072","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011072/doc4.xml","form_type":"4"}},{"id":1713019,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-14T00:04:46.000Z","date":"2023-12-13","kind":"sale","planned":true,"acquired":false,"shares":13722,"price":75.12,"value":1030796.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $74.530 to $75.510. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4485.82,"source":{"system":"sec-edgar","filing":"0001225208-23-011072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011072/doc4.xml","form_type":"4"}},{"id":1713018,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-14T00:04:46.000Z","date":"2023-12-13","kind":"sale","planned":true,"acquired":false,"shares":10600,"price":74.22,"value":786732.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $73.520 to $74.515. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18207.82,"source":{"system":"sec-edgar","filing":"0001225208-23-011072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011072/doc4.xml","form_type":"4"}},{"id":1713017,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-14T00:04:46.000Z","date":"2023-12-13","kind":"sale","planned":true,"acquired":false,"shares":3200,"price":73.15,"value":234080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $72.510 to $73.510. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28807.82,"source":{"system":"sec-edgar","filing":"0001225208-23-011072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011072/doc4.xml","form_type":"4"}},{"id":1713016,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-14T00:04:46.000Z","date":"2023-12-13","kind":"sale","planned":true,"acquired":false,"shares":1828,"price":75.73,"value":138434.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $75.560 to $75.970. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":32007.82,"source":{"system":"sec-edgar","filing":"0001225208-23-011072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011072/doc4.xml","form_type":"4"}},{"id":1713015,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-14T00:04:46.000Z","date":"2023-12-13","kind":"exercise","planned":true,"acquired":true,"shares":29350,"price":36.75,"value":1078612.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."}],"balance_after":33835.82,"source":{"system":"sec-edgar","filing":"0001225208-23-011072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011072/doc4.xml","form_type":"4"}},{"id":1748964,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-11-06T23:33:57.000Z","date":"2023-11-03","kind":"exercise","planned":true,"acquired":false,"shares":29350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":176100,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":29350},"source":{"system":"sec-edgar","filing":"0001225208-23-010019","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823010019/doc4.xml","form_type":"4"}},{"id":1748963,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-06T23:33:57.000Z","date":"2023-11-06","kind":"gift","planned":true,"acquired":true,"shares":371689,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Living Trust"},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"In connection with an in-kind transfer of shares from the Reporting Person's 401(k) account to his Living Trust, the remaining 0.7321 of one share was automatically sold by the 401(k) plan administrator at a price of $63.505269 per share, for a total of $46.50, to comply with the plan administrator's policy prohibiting the transfer of a fractional share."}],"balance_after":4038377,"source":{"system":"sec-edgar","filing":"0001225208-23-010019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823010019/doc4.xml","form_type":"4"}},{"id":1748962,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-06T23:33:57.000Z","date":"2023-11-06","kind":"gift","planned":true,"acquired":false,"shares":371689,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"401(k)"},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"In connection with an in-kind transfer of shares from the Reporting Person's 401(k) account to his Living Trust, the remaining 0.7321 of one share was automatically sold by the 401(k) plan administrator at a price of $63.505269 per share, for a total of $46.50, to comply with the plan administrator's policy prohibiting the transfer of a fractional share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001225208-23-010019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823010019/doc4.xml","form_type":"4"}},{"id":1748961,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-06T23:33:57.000Z","date":"2023-11-03","kind":"sale","planned":true,"acquired":false,"shares":29350,"price":67.18,"value":1971733.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $66.59 to $67.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4485.82,"source":{"system":"sec-edgar","filing":"0001225208-23-010019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823010019/doc4.xml","form_type":"4"}},{"id":1748960,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-06T23:33:57.000Z","date":"2023-11-03","kind":"exercise","planned":true,"acquired":true,"shares":29350,"price":36.75,"value":1078612.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."}],"balance_after":33835.82,"source":{"system":"sec-edgar","filing":"0001225208-23-010019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823010019/doc4.xml","form_type":"4"}},{"id":1770823,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-10-02T22:51:47.000Z","date":"2023-10-02","kind":"exercise","planned":true,"acquired":false,"shares":29350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":205450,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":29350},"source":{"system":"sec-edgar","filing":"0001225208-23-009136","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823009136/doc4.xml","form_type":"4"}},{"id":1770822,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-02T22:51:47.000Z","date":"2023-10-02","kind":"sale","planned":true,"acquired":false,"shares":29350,"price":68.84,"value":2020454.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $68.39 to $69.18. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4485.82,"source":{"system":"sec-edgar","filing":"0001225208-23-009136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823009136/doc4.xml","form_type":"4"}},{"id":1770821,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-02T22:51:47.000Z","date":"2023-10-02","kind":"exercise","planned":true,"acquired":true,"shares":29350,"price":36.75,"value":1078612.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."}],"balance_after":33835.82,"source":{"system":"sec-edgar","filing":"0001225208-23-009136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823009136/doc4.xml","form_type":"4"}},{"id":1789807,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-09-05T23:08:45.000Z","date":"2023-09-05","kind":"exercise","planned":true,"acquired":false,"shares":29350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":234800,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":29350},"source":{"system":"sec-edgar","filing":"0001225208-23-008709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008709/doc4.xml","form_type":"4"}},{"id":1789806,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-09-05T23:08:45.000Z","date":"2023-09-05","kind":"sale","planned":true,"acquired":false,"shares":29350,"price":75.86,"value":2226491.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $75.40 to $76.24. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4485.82,"source":{"system":"sec-edgar","filing":"0001225208-23-008709","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008709/doc4.xml","form_type":"4"}},{"id":1789805,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-09-05T23:08:45.000Z","date":"2023-09-05","kind":"exercise","planned":true,"acquired":true,"shares":29350,"price":36.75,"value":1078612.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."}],"balance_after":33835.82,"source":{"system":"sec-edgar","filing":"0001225208-23-008709","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008709/doc4.xml","form_type":"4"}},{"id":1792209,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-31T21:34:36.000Z","date":"2023-08-31","kind":"gift","planned":false,"acquired":true,"shares":49766,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Living Trust"},"balance_after":3666688,"source":{"system":"sec-edgar","filing":"0001225208-23-008597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008597/doc4.xml","form_type":"4"}},{"id":1792208,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-31T21:34:36.000Z","date":"2023-08-31","kind":"gift","planned":false,"acquired":false,"shares":49766,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4485.82,"source":{"system":"sec-edgar","filing":"0001225208-23-008597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008597/doc4.xml","form_type":"4"}},{"id":1814128,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-08-07T23:20:39.000Z","date":"2023-08-07","kind":"exercise","planned":true,"acquired":false,"shares":29350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":264150,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":29350},"source":{"system":"sec-edgar","filing":"0001225208-23-008065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008065/doc4.xml","form_type":"4"}},{"id":1814127,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-07T23:20:39.000Z","date":"2023-08-07","kind":"sale","planned":true,"acquired":false,"shares":29050,"price":79.86,"value":2319933.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $79.490 to $80.485. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":54251.82,"source":{"system":"sec-edgar","filing":"0001225208-23-008065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008065/doc4.xml","form_type":"4"}},{"id":1814126,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-07T23:20:39.000Z","date":"2023-08-07","kind":"sale","planned":true,"acquired":false,"shares":300,"price":80.54,"value":24162.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $80.510 to $80.570. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":83301.82,"source":{"system":"sec-edgar","filing":"0001225208-23-008065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008065/doc4.xml","form_type":"4"}},{"id":1814125,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-07T23:20:39.000Z","date":"2023-08-07","kind":"exercise","planned":true,"acquired":true,"shares":29350,"price":36.75,"value":1078612.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."}],"balance_after":83601.82,"source":{"system":"sec-edgar","filing":"0001225208-23-008065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008065/doc4.xml","form_type":"4"}},{"id":1837525,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-07-06T00:13:32.000Z","date":"2023-07-05","kind":"exercise","planned":true,"acquired":false,"shares":29350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":293500,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":29350},"source":{"system":"sec-edgar","filing":"0001225208-23-007306","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823007306/doc4.xml","form_type":"4"}},{"id":1837524,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-06T00:13:32.000Z","date":"2023-07-05","kind":"sale","planned":true,"acquired":false,"shares":21728,"price":90.63,"value":1969208.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $90.09 to $91.09 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":54251.82,"source":{"system":"sec-edgar","filing":"0001225208-23-007306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823007306/doc4.xml","form_type":"4"}},{"id":1837523,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-06T00:13:32.000Z","date":"2023-07-05","kind":"sale","planned":true,"acquired":false,"shares":7622,"price":91.22,"value":695278.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $91.10 to $91.50 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":75979.82,"source":{"system":"sec-edgar","filing":"0001225208-23-007306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823007306/doc4.xml","form_type":"4"}},{"id":1837522,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-06T00:13:32.000Z","date":"2023-07-05","kind":"exercise","planned":true,"acquired":true,"shares":29350,"price":36.75,"value":1078612.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."}],"balance_after":83601.82,"source":{"system":"sec-edgar","filing":"0001225208-23-007306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823007306/doc4.xml","form_type":"4"}},{"id":1872493,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-06-02T00:11:05.000Z","date":"2023-06-01","kind":"exercise","planned":true,"acquired":false,"shares":29350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":322850,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":29350},"source":{"system":"sec-edgar","filing":"0001225208-23-006458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823006458/doc4.xml","form_type":"4"}},{"id":1872492,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-02T00:11:05.000Z","date":"2023-06-01","kind":"sale","planned":true,"acquired":false,"shares":18654,"price":84.57,"value":1577568.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $84.025 to $85.020 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":86209.82,"source":{"system":"sec-edgar","filing":"0001225208-23-006458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823006458/doc4.xml","form_type":"4"}},{"id":1872491,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-02T00:11:05.000Z","date":"2023-06-01","kind":"sale","planned":true,"acquired":false,"shares":5396,"price":85.08,"value":459091.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $85.030 to $85.130 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":104863.82,"source":{"system":"sec-edgar","filing":"0001225208-23-006458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823006458/doc4.xml","form_type":"4"}},{"id":1872490,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-02T00:11:05.000Z","date":"2023-06-01","kind":"sale","planned":true,"acquired":false,"shares":5300,"price":83.43,"value":442179.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $83.000 to $84.000 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":110259.82,"source":{"system":"sec-edgar","filing":"0001225208-23-006458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823006458/doc4.xml","form_type":"4"}},{"id":1872489,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-02T00:11:05.000Z","date":"2023-06-01","kind":"exercise","planned":true,"acquired":true,"shares":29350,"price":36.75,"value":1078612.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023."}],"balance_after":115559.82,"source":{"system":"sec-edgar","filing":"0001225208-23-006458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823006458/doc4.xml","form_type":"4"}},{"id":1894020,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Director Stock Option (Right to Acquire)","published_at":"2023-05-15T22:24:41.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":3589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 12, 2023 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and became fully exercisable on the grant date."}],"balance_after":3589,"derivative":{"exercise_price":89.18,"exercise_date":"2023-05-12","expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":3589},"source":{"system":"sec-edgar","filing":"0001225208-23-005912","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005912/doc4.xml","form_type":"4"}},{"id":1894019,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-15T22:24:41.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":4485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 12, 2023 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":86209.82,"source":{"system":"sec-edgar","filing":"0001225208-23-005912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005912/doc4.xml","form_type":"4"}},{"id":1897171,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-05-11T22:11:31.000Z","date":"2023-05-10","kind":"exercise","planned":true,"acquired":false,"shares":29375,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":35.1967,"exercise_date":"2016-06-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":29375},"source":{"system":"sec-edgar","filing":"0001225208-23-005754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005754/doc4.xml","form_type":"4"}},{"id":1897170,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Performance Rights","published_at":"2023-05-11T22:11:31.000Z","date":"2023-05-07","kind":"exercise","planned":true,"acquired":false,"shares":20777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":5698,"derivative":{"exercise_date":"2023-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":20777},"source":{"system":"sec-edgar","filing":"0001225208-23-005754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005754/doc4.xml","form_type":"4"}},{"id":1897169,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-05-11T22:11:31.000Z","date":"2023-05-10","kind":"gift","planned":true,"acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Living Trust"},"balance_after":3616922,"source":{"system":"sec-edgar","filing":"0001225208-23-005754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005754/doc4.xml","form_type":"4"}},{"id":1897168,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-05-11T22:11:31.000Z","date":"2023-05-10","kind":"sale","planned":true,"acquired":false,"shares":13891,"price":88.29,"value":1226436.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $87.83 to $88.83 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":81724.82,"source":{"system":"sec-edgar","filing":"0001225208-23-005754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005754/doc4.xml","form_type":"4"}},{"id":1897167,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-05-11T22:11:31.000Z","date":"2023-05-10","kind":"gift","planned":true,"acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":95615.82,"source":{"system":"sec-edgar","filing":"0001225208-23-005754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005754/doc4.xml","form_type":"4"}},{"id":1897166,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-05-11T22:11:31.000Z","date":"2023-05-10","kind":"sale","planned":true,"acquired":false,"shares":5984,"price":88.94,"value":532216.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $88.84 to $89.25 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":105115.82,"source":{"system":"sec-edgar","filing":"0001225208-23-005754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005754/doc4.xml","form_type":"4"}},{"id":1897165,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-05-11T22:11:31.000Z","date":"2023-05-10","kind":"exercise","planned":true,"acquired":true,"shares":29375,"price":35.1967,"value":1033903.0625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."}],"balance_after":111099.82,"source":{"system":"sec-edgar","filing":"0001225208-23-005754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005754/doc4.xml","form_type":"4"}},{"id":1897164,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-05-11T22:11:31.000Z","date":"2023-05-07","kind":"exercise","planned":true,"acquired":true,"shares":20777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":81724.82,"source":{"system":"sec-edgar","filing":"0001225208-23-005754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005754/doc4.xml","form_type":"4"}},{"id":1919153,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-04-17T20:10:52.000Z","date":"2023-04-14","kind":"exercise","planned":true,"acquired":false,"shares":29375,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":29375,"derivative":{"exercise_price":35.1967,"exercise_date":"2016-06-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":29375},"source":{"system":"sec-edgar","filing":"0001225208-23-004844","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823004844/doc4.xml","form_type":"4"}},{"id":1919152,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-04-17T20:10:52.000Z","date":"2023-04-14","kind":"gift","planned":true,"acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Living Trust"},"balance_after":3607422,"source":{"system":"sec-edgar","filing":"0001225208-23-004844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823004844/doc4.xml","form_type":"4"}},{"id":1919151,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-04-17T20:10:52.000Z","date":"2023-04-14","kind":"sale","planned":true,"acquired":false,"shares":16059,"price":84.1,"value":1350561.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $83.42 to $84.42 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":60947.82,"source":{"system":"sec-edgar","filing":"0001225208-23-004844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823004844/doc4.xml","form_type":"4"}},{"id":1919150,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-04-17T20:10:52.000Z","date":"2023-04-14","kind":"gift","planned":true,"acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":77006.82,"source":{"system":"sec-edgar","filing":"0001225208-23-004844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823004844/doc4.xml","form_type":"4"}},{"id":1919149,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-04-17T20:10:52.000Z","date":"2023-04-14","kind":"sale","planned":true,"acquired":false,"shares":3816,"price":84.61,"value":322871.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $84.43 to $84.88 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":86506.82,"source":{"system":"sec-edgar","filing":"0001225208-23-004844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823004844/doc4.xml","form_type":"4"}},{"id":1919148,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-04-17T20:10:52.000Z","date":"2023-04-14","kind":"exercise","planned":true,"acquired":true,"shares":29375,"price":35.1967,"value":1033903.0625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."}],"balance_after":90322.82,"source":{"system":"sec-edgar","filing":"0001225208-23-004844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823004844/doc4.xml","form_type":"4"}},{"id":1955077,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-03-15T00:47:24.000Z","date":"2023-03-14","kind":"exercise","acquired":false,"shares":29375,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":58750,"derivative":{"exercise_price":35.1967,"exercise_date":"2016-06-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":29375},"source":{"system":"sec-edgar","filing":"0001225208-23-003876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003876/doc4.xml","form_type":"4"}},{"id":1955076,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-03-15T00:47:24.000Z","date":"2023-03-14","kind":"gift","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Living Trust"},"balance_after":3597922,"source":{"system":"sec-edgar","filing":"0001225208-23-003876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003876/doc4.xml","form_type":"4"}},{"id":1955075,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-03-15T00:47:24.000Z","date":"2023-02-15","kind":"gift","acquired":true,"shares":96405,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Living Trust"},"balance_after":3588422,"source":{"system":"sec-edgar","filing":"0001225208-23-003876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003876/doc4.xml","form_type":"4"}},{"id":1955074,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-03-15T00:47:24.000Z","date":"2023-03-14","kind":"sale","acquired":false,"shares":10700,"price":77.86,"value":833102.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $77.625 to $78.170 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":60947.82,"source":{"system":"sec-edgar","filing":"0001225208-23-003876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003876/doc4.xml","form_type":"4"}},{"id":1955073,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-03-15T00:47:24.000Z","date":"2023-03-14","kind":"gift","acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":71647.82,"source":{"system":"sec-edgar","filing":"0001225208-23-003876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003876/doc4.xml","form_type":"4"}},{"id":1955072,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-03-15T00:47:24.000Z","date":"2023-03-14","kind":"sale","acquired":false,"shares":9175,"price":77.32,"value":709411.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $76.620 to $77.620 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":81147.82,"source":{"system":"sec-edgar","filing":"0001225208-23-003876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003876/doc4.xml","form_type":"4"}},{"id":1955071,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-03-15T00:47:24.000Z","date":"2023-03-14","kind":"exercise","acquired":true,"shares":29375,"price":35.1967,"value":1033903.0625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."}],"balance_after":90322.82,"source":{"system":"sec-edgar","filing":"0001225208-23-003876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003876/doc4.xml","form_type":"4"}},{"id":1955070,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-03-15T00:47:24.000Z","date":"2023-02-15","kind":"gift","acquired":false,"shares":96405,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60947.82,"source":{"system":"sec-edgar","filing":"0001225208-23-003876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003876/doc4.xml","form_type":"4"}},{"id":2017505,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-02-15T00:14:53.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":29375,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":88125,"derivative":{"exercise_price":35.1967,"exercise_date":"2016-06-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":29375},"source":{"system":"sec-edgar","filing":"0001225208-23-001936","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823001936/doc4.xml","form_type":"4"}},{"id":2017504,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T00:14:53.000Z","date":"2023-02-14","kind":"gift","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Living Trust"},"balance_after":3492017,"source":{"system":"sec-edgar","filing":"0001225208-23-001936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823001936/doc4.xml","form_type":"4"}},{"id":2017503,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T00:14:53.000Z","date":"2023-02-14","kind":"sale","acquired":false,"shares":16275,"price":76.83,"value":1250408.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $76.280 to $77.280 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":157352.82,"source":{"system":"sec-edgar","filing":"0001225208-23-001936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823001936/doc4.xml","form_type":"4"}},{"id":2017502,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T00:14:53.000Z","date":"2023-02-14","kind":"gift","acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":173627.82,"source":{"system":"sec-edgar","filing":"0001225208-23-001936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823001936/doc4.xml","form_type":"4"}},{"id":2017501,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T00:14:53.000Z","date":"2023-02-14","kind":"sale","acquired":false,"shares":3600,"price":77.75,"value":279900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $77.285 to $78.110 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":183127.82,"source":{"system":"sec-edgar","filing":"0001225208-23-001936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823001936/doc4.xml","form_type":"4"}},{"id":2017500,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T00:14:53.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":29375,"price":35.1967,"value":1033903.0625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."}],"balance_after":186727.82,"source":{"system":"sec-edgar","filing":"0001225208-23-001936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823001936/doc4.xml","form_type":"4"}},{"id":2055040,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-01-13T23:41:05.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":29375,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":117500,"derivative":{"exercise_price":35.1967,"exercise_date":"2016-06-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":29375},"source":{"system":"sec-edgar","filing":"0001225208-23-000630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823000630/doc4.xml","form_type":"4"}},{"id":2055039,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-01-13T23:41:05.000Z","date":"2023-01-13","kind":"gift","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Living Trust"},"balance_after":3482517,"source":{"system":"sec-edgar","filing":"0001225208-23-000630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823000630/doc4.xml","form_type":"4"}},{"id":2055038,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-01-13T23:41:05.000Z","date":"2023-01-13","kind":"sale","acquired":false,"shares":19875,"price":78.0943,"value":1552124.2125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $77.43 to $78.40 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":157352.82,"source":{"system":"sec-edgar","filing":"0001225208-23-000630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823000630/doc4.xml","form_type":"4"}},{"id":2055037,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-01-13T23:41:05.000Z","date":"2023-01-13","kind":"gift","acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":177227.82,"source":{"system":"sec-edgar","filing":"0001225208-23-000630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823000630/doc4.xml","form_type":"4"}},{"id":2055036,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-01-13T23:41:05.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":29375,"price":35.1967,"value":1033903.0625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."}],"balance_after":186727.82,"source":{"system":"sec-edgar","filing":"0001225208-23-000630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823000630/doc4.xml","form_type":"4"}},{"id":2086897,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-12-14T23:49:48.000Z","date":"2022-12-14","kind":"exercise","acquired":false,"shares":29375,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":146875,"derivative":{"exercise_price":35.1967,"exercise_date":"2016-06-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":29375},"source":{"system":"sec-edgar","filing":"0001225208-22-012780","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822012780/doc4.xml","form_type":"4"}},{"id":2086896,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-12-14T23:49:48.000Z","date":"2022-12-14","kind":"gift","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Living Trust"},"balance_after":3473017,"source":{"system":"sec-edgar","filing":"0001225208-22-012780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822012780/doc4.xml","form_type":"4"}},{"id":2086895,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-12-14T23:49:48.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":12155,"price":76.04,"value":924266.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $75.480 to $76.480 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":157352.82,"source":{"system":"sec-edgar","filing":"0001225208-22-012780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822012780/doc4.xml","form_type":"4"}},{"id":2086894,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-12-14T23:49:48.000Z","date":"2022-12-14","kind":"gift","acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":169507.82,"source":{"system":"sec-edgar","filing":"0001225208-22-012780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822012780/doc4.xml","form_type":"4"}},{"id":2086893,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-12-14T23:49:48.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":7420,"price":76.93,"value":570820.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $76.485 to $77.480 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":179007.82,"source":{"system":"sec-edgar","filing":"0001225208-22-012780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822012780/doc4.xml","form_type":"4"}},{"id":2086892,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-12-14T23:49:48.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":300,"price":77.51,"value":23253.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."}],"balance_after":186427.82,"source":{"system":"sec-edgar","filing":"0001225208-22-012780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822012780/doc4.xml","form_type":"4"}},{"id":2086891,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-12-14T23:49:48.000Z","date":"2022-12-14","kind":"exercise","acquired":true,"shares":29375,"price":35.1967,"value":1033903.0625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022."}],"balance_after":186727.82,"source":{"system":"sec-edgar","filing":"0001225208-22-012780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822012780/doc4.xml","form_type":"4"}},{"id":2118752,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-11-15T00:00:35.000Z","date":"2022-11-14","kind":"exercise","acquired":false,"shares":29375,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":176250,"derivative":{"exercise_price":35.1967,"exercise_date":"2016-06-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":29375},"source":{"system":"sec-edgar","filing":"0001225208-22-011662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822011662/doc4.xml","form_type":"4"}},{"id":2118751,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91594,"kind":"person","name":"MUSSALLEM MICHAEL A","position":1,"cik":"0001204551","reported_name":"MUSSALLEM MICHAEL A","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-11-15T00:00:35.000Z","date":"2022-11-14","kind":"gift","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Living Trust"},"balance_after":3463517,"source":{"system":"sec-edgar","filing":"0001225208-22-011662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822011662/doc4.xml","form_type":"4"}}],"next_cursor":"2022-11-15T00:00:35.000000Z,2118751"}